Medium impact
Chimeric Antigen Receptor (CAR) T-cell Therapy - Medicare Advantage (Revised)
Humana·Effective Sep 2, 2025
CPT 38225, in plain terms, covers A doctor collects blood cells and genetically modifies them in a lab to fight cancer before returning them to the patient's body. CPT 38225 is referenced in 1 tracked payer policy change from Humana. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 38225 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Official descriptor: CPT 38225 on AAPC
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.